Literature DB >> 16191067

Uremic pruritus: a review.

Jocemir R Lugon1.   

Abstract

Pruritus is a major disorder among the skin derangements in advanced renal failure. Its prevalence seems to be diminishing perhaps because of improvements in dialysis treatment. Recent information suggests that interactions between dermal mast cells and distal ends of nonmyelinated C fibers may be important in the precipitation and regulation of the sensory stimuli. The knowledge as to the control of pruritus transmission to cortex areas is still incomplete but endogenous opioid and opioid receptors may have a role in this regard. A recent classification was proposed for pruritus based on the level of its origin. Uremic pruritus, however, seems to be too complex to fit perfectly in any of the suggested modalities. Inflammation and malnutrition are recognized risk factors for cardiovascular death in end-stage renal disease patients, which may be related to the genesis of pruritus. Consistent with this concept, lower serum levels of albumin and higher serum levels of ferritin were found in pruritic patients when compared to nonpruritic ones. Newer treatments for this difficult clinical problem are being developed and tested.

Entities:  

Mesh:

Year:  2005        PMID: 16191067     DOI: 10.1111/j.1492-7535.2005.01130.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  22 in total

1.  Pruritus in the elderly: clinical approaches to the improvement of quality of life.

Authors:  Kenneth R Cohen; Jerry Frank; Rebecca L Salbu; Igor Israel
Journal:  P T       Date:  2012-04

2.  Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study.

Authors:  Mahmoud Gholyaf; Vida Sheikh; Fatemeh Yasrebifar; Younes Mohammadi; Mahtabalsadat Mirjalili; Maryam Mehrpooya
Journal:  Int Urol Nephrol       Date:  2020-05-07       Impact factor: 2.370

Review 3.  Pruritus in Kidney Disease.

Authors:  Sara A Combs; J Pedro Teixeira; Michael J Germain
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

4.  Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial.

Authors:  Maryam Pakfetrat; Fatemeh Basiri; Leila Malekmakan; Jamshid Roozbeh
Journal:  J Nephrol       Date:  2014-01-31       Impact factor: 3.902

5.  Effect of sertraline on uremic pruritus improvement in ESRD patients.

Authors:  Mansor Shakiba; Hoshang Sanadgol; Hamid Reza Azmoude; Mohamad Ali Mashhadi; Hassan Sharifi
Journal:  Int J Nephrol       Date:  2012-08-29

6.  The effects of an interventional program based on self-care model on health-related quality of life outcomes in hemodialysis patients.

Authors:  Mohammadkarim Bahadori; Fatemeh Ghavidel; Shahla Mohammadzadeh; Ramin Ravangard
Journal:  J Educ Health Promot       Date:  2014-11-29

7.  Association of systemic diseases with cutaneous dermatosis in elderly population: preliminary observation at a rural tertiary care centre.

Authors:  Pragya A Nair; Rita Vora
Journal:  J Family Med Prim Care       Date:  2015 Jan-Mar

8.  B-type (brain) natriuretic peptide and pruritus in hemodialysis patients.

Authors:  Yoshio Shimizu; Ayano Sonoda; Chieko Nogi; Yoko Ogushi; Reo Kanda; Saori Yamaguchi; Nao Nohara; Tatsuya Aoki; Kaori Yamada; Junichiro Nakata; Hiroaki Io; Atsushi Kurusu; Chieko Hamada; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-08-25

9.  Efficacy of omega-3 fatty acids supplementation in treatment of uremic pruritus in hemodialysis patients: a double-blind randomized controlled trial.

Authors:  E Ghanei; J Zeinali; M Borghei; M Homayouni
Journal:  Iran Red Crescent Med J       Date:  2012-09-30       Impact factor: 0.611

10.  Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study.

Authors:  Pornanong Aramwit; Orathai Keongamaroon; Tippawan Siritientong; Nipaporn Bang; Ouppatham Supasyndh
Journal:  BMC Nephrol       Date:  2012-09-24       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.